Patient-reported outcomes after personalised dose-escalation for stage II-III non-small-cell lung cancer patients: Results from the randomised ARTFORCE PET-Boost trial
- Resource Type
- Article
- Source
- In
Radiotherapy and Oncology July 2024 196 - Subject
- Language
- ISSN
- 0167-8140